The effects of lineage differentiation into pancreatic beta-cells on the immunogenicity of amniotic fluid stem cells.
The use of stem cells for curing disease and ending disabilities may change the medical treatment in this century. However, there are some major roadblocks that need to be resolved before these cells are implemented in ordinary medical care.
Short name and number:
OXFORDWINSTON (221850)
Name of US Partner:
WAKE FOREST UNIVERSITY HEALTH SCIENCES
Contact:
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (UK) / DOLTON Monica
Participating Countries:
United States
Area:
Health
Category:
FP7 Project with U.S. partner
